Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2021 | Tackling GvHD together

Kirk Schultz • 15 Mar 2021
EBMT 2021

Kirk Schultz, MD, British Columbia Children’s Hospital, Vancouver, Canada, talks on how the community is gearing to tackle graft-versus-host disease (GvHD) in the future, highlighting the 3rd NIH Chronic GvHD Consensus Conference. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

More from Kirk Schultz

Identifying operational tolerance pathways after SCT & cGvHD immune profiles with machine learning
1:07
Identifying operational tolerance pathways after SCT & cGvHD immune profiles with machine learning
Kirk Schultz • 23 Apr 2023
GvHD biomarker discovery and validation
2:25
GvHD biomarker discovery and validation
Kirk Schultz • 15 Mar 2021
Abatacept for prevention of acute GVHD
0:41
Abatacept for prevention of acute GVHD
Kirk Schultz • 15 Mar 2021
The content of VJHemOnc is intended for healthcare professionals